
Skip to main content


{"utility":"globan","theme":"light","logo":true,"link":true,"mode":false}













en
Select your language
Close
bg
български
es
español
cs
čeština
da
dansk
de
Deutsch
et
eesti
el
ελληνικά
en
English
fr
français
ga
Gaeilge
hr
hrvatski
it
italiano
lv
latviešu
lt
lietuvių
hu
magyar
mt
Malti
nl
Nederlands
pl
polski
pt
português
ro
română
sk
slovenčina
sl
slovenščina
fi
suomi
sv
svenska



{"service":"search","version":"2.0","form":".ecl-search-form","filters":{"scope":{"sites":[{"selected":true,"name":"Public Health","id":["comm-ewcms-health"]}]}}}

Search
Search







































Public Health





Home
…
Medical Devices - Sector
New Regulations
Guidance
Guidance - MDCG endorsed documents and other guidance















Page contents
Page contents






This page provides a range of documents to assist stakeholders in applying:
Regulation (EU) 2017/745 on medical devices (MDR)
and
Regulation (EU) 2017/746 (IVDR) on in vitro diagnostic medical devices
.
The majority of documents on this page are endorsed by the Medical Device Coordination Group (MDCG) in accordance with Article 105 of the MDR and Article 99 of the IVDR.
They are drafted in collaboration with interested parties represented in the various groups and denominated by the following format: “MDCG Year-Number-revision”.
The documents on this page are not legally binding. They present a common understanding of how the MDR and IVDR should be applied in practice aiming at an effective and harmonised implementation of the legislation. Guidance documents are regularly reviewed to see whether they need to be revised or archived.
Obsolete guidance is available here
.
Ongoing development/revision of guidance.
Current guidance
Annex XVI products
Reference
Title
Publication
MDCG 2023-6
Guidance on demonstration of equivalence for Annex XVI products - A guide for manufacturers and notified bodies
December 2023
MDCG 2023-5
Guidance on qualification and classification of Annex XVI products - A guide for manufacturers and notified bodies
December 2023
Q&A
Q&A on transitional provisions for products without an intended medical purpose covered by annex XVI of the MDR
September 2023
Borderline and Classification
Reference
Title
Publication
Manual on Borderline
Manual on borderline and classification under Regulations (EU) 2017/745 and 2017/746 v4
Background note
on the use of the Manual on borderline and classification for medical devices under the Directives.
September 2025
MDCG 2024-13
Regulatory status of ethylene oxide (EtO) intended for the sterilisation of medical devices
October 2024
MDCG 2022-5 rev.1
Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices
October 2024
MDCG 2021-24
Guidance on
classification
of medical devices
October 2021
Helsinki Procedure
Helsinki Procedure
for borderline and classification under MDR & IVDR
September 2021
Class I Devices
Reference
Title
Publication
MDCG 2019-15 rev.1
Guidance notes for
manufacturers of class I
medical devices
December 2019
Clinical investigation and evaluation, performance studies and evaluation
Reference
Title
Publication
MDCG 2025-5
Questions & Answers regarding performance studies of in vitro diagnostic medical devices under regulation (EU) 2017/746
June 2025
MDCG 2024-15
Guidance on the publication of the clinical investigation reports and their summaries in the absence of EUDAMED
November 2024
MDCG 2024-10
Clinical evaluation of orphan medical devices
June 2024
MDCG 2024-5
MDCG 2024-5 Appendix A
Guidance on the Investigator’s Brochure content
Appendix A of the MDCG 2024-5
April2024
April2024
MDCG 2024-3
MDCG 2024-3 Appendix A
Guidance on content of the Clinical Investigation Plan for clinical investigations of medical devices
Clinical Investigation Plan Synopsis Template
March 2024
March 2024
MDCG 2023-7
Guidance on exemptions from the requirement to perform clinical investigations pursuant to Article 61(4)-(6) MDR and on sufficient levels of access’ to data needed to justify claims of equivalence
December 2023
2023/C 163/06
Commission Guidance on the content and structure of the summary of the clinical investigation report
May 2023
MDCG 2021-28
Substantial modification
of clinical investigation under Medical Device Regulation
December 2021
MDCG 2021-20
Instructions for
generating CIV-ID
for MDR Clinical Investigations
July 2021
MDCG 2021-8
Clinical investigation
application/notification documents
May 2021
MDCG 2021-6 - rev.1
Regulation (EU) 2017/745 –
Questions & Answers
regarding
clinical investigation
December 2023
MDCG 2020-13
-
Word version
Clinical evaluation assessment report template
July 2020
MDCG 2020-10/1 rev.1
MDCG 2020-10/2 rev.1
Guidance on
safety reporting
in clinical investigations
Appendix: Clinical investigation summary safety report form
October 2022
October 2022
MDCG 2020-8
Guidance on
PMCF evaluation report
template
April 2020
MDCG 2020-7
Guidance on
PMCF plan
template
April 2020
MDCG 2020-6
Guidance on sufficient
clinical evidence for legacy devices
Background note

on the relationship between MDCG 2020-6 and MEDDEV 2.7/1 rev.4 on clinical evaluation
April 2020
MDCG 2020-5
Guidance on
clinical evaluation – Equivalence
April 2020
MDCG 2019-9 - rev.1
Summary of safety and clinical performance
March 2022
COVID-19
Reference
Title
Publication
MDCG 2021-21 rev.1
Guidance on
performance evaluation of SARS-CoV-2
in vitro diagnostic medical devices
February 2022
MDCG 2022-1
Notice to 3rd country manufacturers
of SARS-CoV-2 in vitro diagnostic medical devices
January 2022
MDCG 2021-7
Notice to manufacturers and authorised representatives on the
impact of genetic variants on SARS-COV-2
in vitro diagnostic medical devices
May 2021
MDCG 2021-2
Guidance on state of the art of
COVID-19 rapid antibody tests
March 2021
COVID-19 TESTS: Q&A on in vitro diagnostic medical device conformity assessment and performance in the context of COVID-19
(available in all EU languages and
Arabic
,
Chinese
,
Japanese
,
Russian
)
February 2021
Conformity assessment procedures for protective equipment
July 2020
How to verify that medical devices and personal protective equipment can be lawfully placed on the EU market and thus purchased and used – also in the COVID-19 context
May 2020
Guidance on regulatory requirements for medical face masks
June 2020
Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 context
April 2020
Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19
April 2020
MDCG 2020-9
Regulatory requirements for
ventilators and related accessories
April 2020
Custom-Made Devices
Reference
Title
Publication
MDCG 2021-3
Questions and Answers
on Custom-Made Devices
March 2021
EUDAMED
EUDAMED Information Centre
Reference
Title
Publication
Gradual roll out of EUDAMED
Q&A on practical aspects related to the implementation of the gradual roll-out of Eudamed pursuant to the MDR and IVDR, as amended by Regulation (EU) 2024/1860 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices1
November 2024
MDCG 2022-12
Guidance on harmonised administrative practices and alternative technical solutions until Eudamed is fully functional (for Regulation (EU) 2017/746 on in vitro diagnostic medical devices)
July 2022
MDCG 2021-13 rev.1
Questions and answers
on obligations and related rules for the
registration
in EUDAMED
of actors other than
manufacturers, authorised representatives and importers subject to the obligations of
Article 31 MDR and Article 28 IVDR
July 2021
MDCG 2021-1 rev.1
Guidance on harmonised administrative practices and
alternative
technical
solutions until EUDAMED is fully functional
May 2021
European Medical Device Nomenclature (EMDN)
Reference
Title
Publication
MDCG 2025-3
EMDN Version History
January 2025
MDCG 2025-2
Summary of EMDN 2024 Submissions and outcome of annual revision
January 2025
MDCG 2025-1
EMDN Ad hoc procedure
January 2025
MDCG 2024-2 rev.1
Procedures for the
updates
of the EMDN
January 2025
MDCG 2021-12 rev.1
FAQ
on the European Medical Device Nomenclature (
EMDN
)
January 2025
The EMDN – The nomenclature of use in EUDAMED
January 2020
The CND nomenclature – Background and general principles
January 2020
MDCG 2018-2
Future EU medical device nomenclature - Description of requirements
March 2018
Implant cards
Reference
Title
Publication
MDCG 2021-11
Guidance on
Implant Card – Device types
May 2021
MDCG 2019-8 v2
Guidance document
implant card
on the application of Article 18 Regulation (EU) 2017/745 on medical devices
March 2020
In-house devices
Reference
Title
Publication
MDCG 2023-1
Guidance on the health institution exemption under Article 5(5) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
January 2023
Authorised Representatives, Importers, Distributors
Reference
Title
Publication
MDCG 2021-27 - rev.1
Questions and Answers on Articles 13 & 14 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
December 2023
MDCG 2022-16
Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746
October 2022
MDCG 2021-26
Q&A on
repackaging & relabelling
activities under Article 16 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
October 2021
Article 10a – interruption or discontinuation of supply
Reference
Title
Publication
Q&A rev.1
Q&A Obligation to inform in case of interruption or discontinuation of supply
December 2024
MDCG 2024-16
Manufacturer Information Form on Interruption or Discontinuation of Supply of certain medical devices and certain in vitro diagnostic medical devices
December 2024
MDCG 2024-16 Annex
Device Identification table
December 2024
In Vitro Diagnostic medical devices (IVD)
Reference
Title
Publication
MDCG 2024-11
Guidance on qualification of in vitro diagnostic medical devices
October 2024
MDCG 2024-4
MDCG 2024-4 Appendix
Safety reporting in performance studies of in vitro diagnostic medical devices under Regulation (EU) 2017/746
Appendix – Performance Study Summary Safety Reporting Form
April 2024
MDCG 2022-9 rev.1
Summary of safety and performance template
April 2024
MDCG 2020-16 rev.4
Guidance on
Classification Rules
for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746
March 2025
MDCG 2022-20
Substantial modification of performance study under Regulation (EU) 2017/746
December  2022
MDCG 2022-19
Performance study application/notification documents under Regulation (EU) 2017/746
December  2022
MDCG 2022-15
Guidance on appropriate surveillance regarding the transitional provisions under Article 110 of the IVDR with regard to devices covered by certificates according to the IVDD
September  2022
MDCG 2021-22 rev.1
Clarification on “first certification for that type of device” and corresponding procedures to be followed by notified bodies, in context of the
consultation of the expert panel
referred to in Article 48(6) of Regulation (EU) 2017/746
September  2022
MDCG 2022-10
Q&A on the interface between Regulation (EU) 536/2014 on clinical trials for medicinal products for human use (CTR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR)
May 2022
MDCG 2022-8
Regulation (EU) 2017/746 - application of IVDR requirements to ‘legacy devices’ and to devices placed on the market prior to 26 May 2022 in accordance with Directive 98/79/EC
May 2022
MDCG 2022-6
Guidance on significant changes regarding the transitional provision under Article 110(3) of the IVDR
May 2022
MDCG 2022-3 rev.1
Verification of manufactured class D IVDs by notified bodies
December 2024
MDCG 2022-2
Guidance on general principles of
clinical evidence
for In Vitro Diagnostic medical devices (IVDs)
January 2022
MDCG 2021-4 rev.1
Application of
transitional provisions
for certification of
class D
in vitro diagnostic medical devices according to Regulation (EU) 2017/746
September 2024
New technologies
Reference
Title
Publication
MDCG 2025-9
Guidance on Breakthrough Devices (BtX) under Regulations 2017/745 & 2017/746
Note:
Pilot to roll-out the guidance is expected to be launched in Q2 2026
December 2025
MDCG 2025-6
FAQ on Interplay between the Medical Devices Regulation (MDR) & In vitro Diagnostic Medical Devices Regulation (IVDR) and the Artificial Intelligence Act (AIA)
June 2025
MDCG 2025-4
Guidance on the safe making available of medical device software (MDSW) apps on online platforms
June 2025
MDCG 2023-4
Medical Device Software (MDSW) – Hardware combinations Guidance on MDSW intended to work in combination with hardware or hardware components
October 2023
Infographic
Is your
software
a Medical Device?
March 2021
MDCG 2020-1
Guidance on
clinical evaluation
(MDR) /
Performance evaluation
(IVDR) of medical device software
March 2020
MDCG 2019-16 rev.1
Guidance on
cybersecurity
for medical devices
July 2020
MDCG 2019-11 rev.1
Qualification and classification of software
- Regulation (EU) 2017/745 and Regulation (EU) 2017/746
June 2025
Notified bodies
Reference
Title
Publication
MDCG 2024-6

Preliminary re-assessment review (PRAR) form template (MDR)
May 2024
MDCG 2024-7 rev.1
MDCG 2021-15/MDCG 2024-7 Annex
Preliminary assessment review (PAR) form template (MDR)
Annex to Application Form & PAR Template MDR (List of documents)
January 2025
MDCG 2024-8 rev.1

MDCG 2021-16/MDCG 2024-8 Annex
Preliminary assessment review (PAR) form template (IVDR)
Annex to Application Form & PAR Template IVDR (List of documents)
January 2025
MDCG 2024-9
Preliminary re-assessment review (PRAR) form template (IVDR)
May 2024
MDCG 2020-3 rev.1
Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD
Note to the reader: Due to technical issues, please disregard the document displayed from 7 September 2023 until 8 September 2023.
September 2023
MDCG 2023-2
MDCG 2023-2 MDR form
MDCG 2023-2 IVDR form
List of Standard Fees
January 2023
MDCG 2022-4 rev.2
Guidance on appropriate surveillance regarding the transitional provisions under Article 120 of the MDR with regard to devices covered by certificates according to the MDD or the AIMDD
May 2024
MDCG 2022-17
MDCG position paper on "hybrid audits"
December 2022
MDCG 2019-6 rev.5
Questions and answers:
Requirements relating to notified bodies
February 2025
MDCG 2022-13 rev.1
Designation, re-assessment and notification of conformity assessment bodies and notified bodies
June 2024
MDCG 2024-12
MDCG 2024-12 Annex I Form
MDCG 2024-12 Annex II Form
Corrective and preventive action (CAPA) plan assessment: guidance and templates for conformity assessment bodies, notified bodies, designating authorities, and joint assessment teams
Annex I: Template CAPA plan and assessment thereon
Annex II: Template JAT review of the CAPA and the DA's opinion
October 2024
MDCG 2021-23
Guidance for notified bodies, distributors and importers on
certification activities
in accordance with Article 16(4) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746
August 2021
MDCG 2021-18
Applied-for scope of
designation and notification of a conformity assessment body
– Regulation (EU) 2017/746 (IVDR)
July 2021
MDCG 2021-17
Applied-for scope of
designation and notification of a conformity assessment body
– Regulation (EU) 2017/745 (MDR)
July 2021
MDCG 2021-16 rev.1
MDCG 2021-16/MDCG 2024-8 Annex
Application form
to be submitted by a conformity assessment body when applying for
designation as notified body
under the in vitro diagnostic devices regulation (
IVDR
)
Annex to Application Form & PAR Template IVDR (List of documents)
January 2025
MDCG 2021-15 rev.1
MDCG 2021-15/MDCG 2024-7 Annex
Application form
to be submitted by a conformity assessment body when applying for
designation as notified body
under the medical devices regulation (
MDR
)
Annex to Application Form & PAR Template MDR (List of documents)
January 2025
MDCG 2021-14
Explanatory note on
IVDR codes
July 2021
MDCG 2020-17
Questions and Answers related to MDCG 2020-4:
“Guidance on temporary extraordinary measures related to medical device notified body
audits during COVID-19
quarantine orders and travel restrictions”
December 2020
MDCG 2020-14
Guidance for notified bodies on the use of MDSAP audit reports in the context of surveillance audits carried out under the Medical Devices Regulation (MDR)/In Vitro Diagnostic medical devices Regulation (IVDR)
August 2020
MDCG 2020-12
Guidance on transitional provisions for consultations of authorities on devices incorporating a substance which may be considered a medicinal product and which has action ancillary to that of the device, as well as on devices manufactured using TSE susceptible animal tissues
June 2020
MDCG 2020-11
Guidance on the renewal of designation and monitoring of notified bodies under Directives 90/385/EEC and 93/42/EEC to be performed in accordance with Commission Implementing Regulation (EU) 2020/666 amending Commission Implementing Regulation (EU) 920/2013
May 2020
MDCG 2020-4
Guidance on temporary extraordinary measures related to medical device notified body audits during COVID-19 quarantine orders and travel restrictions
April 2020
MDCG 2019-14
Explanatory note on MDR codes
December 2019
MDCG 2019-13 rev.1
Guidance on sampling of devices for the assessment of the technical documentation
December 2024
MDCG 2019-12
Designating authority's final assessment form: Key information (EN)
October 2019
MDCG 2018-8
Guidance on content of the certificates, voluntary certificate transfers
November 2018
NBOG BPG 2017-2
Best practice guidance on the information required for personnel involved in conformity assessment
February 2018
NBOG F 2017-8
Review of qualification for the authorisation of personnel (IVDR)
February 2018
NBOG F 2017-7
Review of qualification for the authorisation of personnel (MDR)
February 2018
Person responsible for regulatory compliance (PRRC)
Reference
Title
Publication
MDCG 2019-7 - rev.1
Guidance on article 15 of the medical device regulation (MDR) and in vitro diagnostic device regulation (IVDR) on a ‘
person responsible for regulatory compliance
’ (PRRC)
December 2023
Post-Market Surveillance and Vigilance (PMSV)
PMSV reporting forms
(Update 22 December 2025)
Reference
Title
Publication
MDCG 2025–10
Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devices
December 2025
MDCG 2024-1
Device Specific Vigilance Guidance (DSVG) Template
January 2024
MDCG 2024-1-1
DSVG 01 on Cardiac ablation
January 2024
MDCG 2024-1-2
DSVG 02 on Coronary stents
January 2024
MDCG 2024-1-3
DSVG 03 on Cardiac implantable electronic devices (CIEDs)
January 2024
MDCG 2024-1-4
DSVG 04 on Breast implants
January 2024
MDCG 2024-1-5
DSVG 05 on Urogynaecological Surgical Mesh Implants used for Pelvic Organ Prolapse repair and Stress Urinary Incontinence
June 2024
MDCG 2023-3 rev.2

Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746
January 2025
MDCG 2022-21
Guidance on Periodic Safety Update Report (PSUR) according to Regulation (EU) 2017/745
December 2022
Standards
Reference
Title
Publication
MDCG 2021-5 rev.1
Guidance on
standardisation for medical devices
July 2024
Unique Device Identifier (UDI)
UDI Helpdesk
Reference
Title
Publication
MDCG 2025-8
Guidance on the implementation of the Master UDI-DI solution for spectacle frames, spectacle lenses and ready-to-wear reading spectacles
November 2025
MDCG 2025-7
Rev 1
MDCG Position Paper: Timelines of the implementation of ‘Master UDI-DI’ to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
December 2025
MDCG 2024-14 - rev.1
Guidance on the implementation of the Master UDI-DI solution for contact lenses
August 2025
MDCG 2022-7
Q&A on the Unique Device Identification system under Regulation (EU) 2017/745 and Regulation (EU)
May 2022
MDCG 2021-19
Guidance note integration of the
UDI
within an organisation’s
quality management system
July 2021
MDCG 2021-10
The status of Appendixes
E-I of IMDRF N48
under the EU regulatory framework for medical devices
June 2021
MDCG 2018-1 rev.4
Guidance on
basic UDI-DI and changes to UDI-DI
April 2021
MDCG 2019-2
Guidance on application of
UDI rules to device-part of products
referred to in article 1(8), 1(9) and 1(10) of Regulation 745/2017
February 2019
MDCG 2019-1
MDCG guiding principles for
issuing entities rules on basic UDI-DI
January 2019
MDCG 2018-7
Provisional considerations regarding
language issues
associated with the
UDI database
October 2018
MDCG 2018-6
Clarifications of
UDI related responsibilities
in relation to
article 16
October 2018
MDCG 2018-5
UDI assignment
to medical device
software
October 2018
MDCG 2018-4
Definitions/descriptions and formats of the
UDI core elements for systems or procedure packs
October 2018
MDCG 2018-3 rev.1
Guidance on
UDI for systems and procedure packs
June 2020
Other topics
Reference
Title
Publication
Q&A
Q&A on practical aspects related to the implementation of the extended transitional period provided for in the IVDR, as amended by Regulation (EU) 2024/1860
July 2024
MDCG 2022-11 - rev.1
MDCG Position Paper: Notice to manufacturers to ensure timely compliance with MDR and IVDR requirements
November 2023
Q&A rev.2
Q&A on practical aspects related to the implementation of Regulation (EU) 2023/607 - Extension of the MDR transitional period and removal of the “sell off” periods
July 2024
MDCG 2022-18 ADD.1
MDCG Position Paper on the application of Article 97 MDR to legacy devices for which the MDD or AIMDD certificate expires before the issuance of a MDR certificate - Addendum 1
June 2023
MDCG 2022-18
MDCG Position Paper on the application of Article 97 MDR to legacy devices for which the MDD or AIMDD certificate expires before the issuance of a MDR certificate
December 2022
MDCG 2022-14
Transition to the MDR and IVDR - Notified body capacity and availability of medical devices and IVDs
August 2022
MDCG 2021-25 rev.1
Application of MDR requirements to "
legacy devices
" and to devices placed on the market prior to 26 May 2021 in accordance with Directives 90/385/EEC or 93/42/EEC
October 2024
MDCG 2019-3 rev.1
Clinical evaluation consultation procedure exemptions
Interpretation of article 54(2)b
April 2020
Other guidance documents
Reference
Title
Publication
MDR/IVDR Language requirements
Overview of language requirements for manufacturers of medical devices for the information and instructions that accompany a device in a specific country
January 2024
European Medicines Agency (EMA) Guidance
Questions & Answers for applicants, marketing authorisation holders of medicinal products and notified bodies with respect to the implementation of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations ((EU) 2017/745 and (EU) 2017/746)
June 2021
SCHEER guidelines
Update on the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices
covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
June 2024
CAMD FAQ
CAMD MDR/IVDR Transition Subgroup: FAQ – MDR Transitional provisions
January 2018










Latest updates

News announcement
19 December 2025
MDCG 2025–10: Guidance on post-market surveillance of medical devices and in vitro diagnostic medical devices (December 2025)
1 min read
News announcement
17 December 2025
MDCG 2025-7 - Rev. 1:  Timelines of the implementation of ‘Master UDI-DI’ to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles
1 min read
News announcement
16 December 2025
New measures to make EU health sector more innovative, competitive and resilient
1 min read
News announcement
16 December 2025
Factsheet - Better rules for medical devices, better outcomes for EU patients
1 min read
See all








Documents

Events
Publications













Obsolete guidance
The guidance documents are regularly reviewed to see whether they need to be revised or archived. This page lists the obsolete guidance
PMSV reporting forms
PMSV reporting forms





Share this page

{"service":"share","version":"2.0","networks":["twitter","facebook","linkedin","email","more"],"display":"icons","stats":true,"selection":true}








Public Health
This site is managed by:
Directorate-General for Health and Food Safety
Latest updates
EU One Health
Health & Food Safety Newsletters
EU public health – databases and other online services
About us
Directorate-General for Health and Food Safety
Related links
EU Health Policy Platform
Food Safety
Follow the European Commission
Facebook
Instagram
X
Linkedin
Other
Contact us
Report an IT vulnerability
Languages on our websites
Cookies
Privacy policy
Legal notice
Accessibility


{"utility":"piwik","siteID":"f573665d-3da7-4fad-8552-baccf7ee0b46","sitePath":["health.ec.europa.eu"],"instance":"ec","dimensions":[{"id":3,"value":"Page"},{"id":4,"value":"medical-device"},{"id":5,"value":"Directorate-General-for-Health-and-Food-Safety"},{"id":6,"value":"Guidance - MDCG endorsed documents and other guidance"},{"id":7,"value":"862a13f5-90c2-4262-b9db-80364b647731"},{"id":8,"value":"EC - STANDARDISED"},{"id":9,"value":"medical-device organisation-of-health-care health-policy"},{"id":10,"value":"Default landing page"},{"id":12,"value":"1078"}]}

{"utility":"cck"}

{"service":"laco","include":"#block-ewcms-theme-main-page-content .ecl","coverage":{"document":"any","page":"any"},"icon":"all","exclude":".nolaco, .ecl-file, .ecl-content-item__title","ignore":["filename=([A-Za-z0-9\\-\\_]+)_([A-Za-z]{2}).pdf"]}

{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/1095","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","urlSuffixes":["bg","es","cs","da","de","et","el","en","fr","ga","hr","it","lv","lt","hu","mt","nl","pl","pt","ro","sk","sl","fi","sv","ar","ca","is","no","tr","uk","ru","zh","lb","sw","he","ja","kl"]},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ewcms_multilingual":{"monolingual":false,"current_node_available_translations":["en"],"machine_translation_script":{"json":"{\u0022service\u0022:\u0022etrans\u0022,\u0022renderAs\u0022:false,\u0022user\u0022:\u0022Public Health\u0022,\u0022exclude\u0022:\u0022.ecl-site-header__language-item,.ecl-site-header__language-selector,.toolbar\u0022,\u0022languages\u0022:{\u0022source\u0022:\u0022en\u0022,\u0022available\u0022:[\u0022en\u0022]},\u0022config\u0022:{\u0022live\u0022:false,\u0022mode\u0022:\u0022lc2023\u0022,\u0022targets\u0022:{\u0022receiver\u0022:\u0022#webtools-etrans\u0022}}}","current_node_language":"en"},"machine_translation":{"available_languages":["bg","cs","da","de","el","en","es","et","fi","fr","ga","hr","hu","it","lt","lv","mt","nl","pl","pt-pt","ro","sk","sl","sv"],"current_node_language_code":"en","native_languages":{"bg":"\u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438","es":"espa\u00f1ol","cs":"\u010de\u0161tina","da":"dansk","de":"Deutsch","et":"eesti","el":"\u03b5\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","en":"English","fr":"fran\u00e7ais","ga":"Gaeilge","hr":"hrvatski","it":"italiano","lv":"latvie\u0161u","lt":"lietuvi\u0173","hu":"magyar","mt":"Malti","nl":"Nederlands","pl":"polski","pt-pt":"portugu\u00eas","ro":"rom\u00e2n\u0103","sk":"sloven\u010dina","sl":"sloven\u0161\u010dina","fi":"suomi","sv":"svenska","ar":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","ca":"catal\u00e0","is":"\u00edslenska","he":"\u05e2\u05d1\u05e8\u05d9\u05ea","kl":"kalaallisut","ja":"\u65e5\u672c\u8a9e","lb":"L\u00ebtzebuergesch","nb":"norsk","ru":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","sw":"Kiswahili","tr":"t\u00fcrk\u00e7e","uk":"y\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","zh-hans":"\u4e2d\u6587"},"suffix_map":{"bg":"bg","es":"es","cs":"cs","da":"da","de":"de","et":"et","el":"el","en":"en","fr":"fr","ga":"ga","hr":"hr","it":"it","lv":"lv","lt":"lt","hu":"hu","mt":"mt","nl":"nl","pl":"pl","pt":"pt-pt","ro":"ro","sk":"sk","sl":"sl","fi":"fi","sv":"sv"},"etrans_enabled":true,"etrans_languages":["ar","bg","cs","da","de","el","en","es","et","fi","fr","ga","hr","hu","is","it","ja","lt","lv","mt","nb","nl","pl","pt-pt","ro","ru","sk","sl","sv","tr","uk","zh-hans"],"non_eu_languages":["ar","ca","he","is","ja","kl","lb","nb","ru","sw","tr","uk","zh-hans"],"translated_strings":{"translation_not_available":{"bg":"\u0422\u0430\u0437\u0438 \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u0430 \u043d\u0435 \u0435 \u0434\u043e\u0441\u0442\u044a\u043f\u043d\u0430 \u043d\u0430 \u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438 \u0435\u0437\u0438\u043a.","es":"Esta p\u00e1gina no est\u00e1 disponible en espa\u00f1ol","cs":"Tato str\u00e1nka nen\u00ed v \u010de\u0161tin\u011b k dispozici","da":"Denne side er ikke tilg\u00e6ngelig p\u00e5 dansk","de":"Diese Seite ist auf Deutsch nicht verf\u00fcgbar.","et":"See lehek\u00fclg ei ole eesti keeles k\u00e4ttesaadav","el":"\u0397 \u03c3\u03b5\u03bb\u03af\u03b4\u03b1 \u03b1\u03c5\u03c4\u03ae \u03b4\u03b5\u03bd \u03b5\u03af\u03bd\u03b1\u03b9 \u03b4\u03b9\u03b1\u03b8\u03ad\u03c3\u03b9\u03bc\u03b7 \u03c3\u03c4\u03b1 \u03b5\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","en":"This page is not available in English.","fr":"Cette page n\u2019est pas disponible en fran\u00e7ais.","ga":"N\u00edl an leathanach seo ar f\u00e1il i nGaeilge","hr":"Ova stranica nije dostupna na hrvatskom jeziku","it":"Questa pagina non \u00e8 disponibile in italiano","lv":"\u0160\u012b lapa nav pieejama latvie\u0161u valod\u0101.","lt":"\u0160io puslapio lietuvi\u0173 kalba n\u0117ra","hu":"Ez az oldal nem \u00e9rhet\u0151 el magyarul","mt":"Din il-pa\u0121na mhix disponibbli bil-Malti","nl":"Deze pagina is niet beschikbaar in het Nederlands.","pl":"Strona nie jest dost\u0119pna w j\u0119zyku polskim.","pt-pt":"Esta p\u00e1gina n\u00e3o est\u00e1 dispon\u00edvel em portugu\u00eas","ro":"Aceast\u0103 pagin\u0103 nu este disponibil\u0103 \u00een limba rom\u00e2n\u0103","sk":"T\u00e1to str\u00e1nka nie je dostupn\u00e1 v sloven\u010dine","sl":"Ta stran ni na voljo v sloven\u0161\u010dini.","fi":"T\u00e4t\u00e4 sivua ei ole saatavilla suomen kielell\u00e4.","sv":"Sidan finns inte p\u00e5 svenska","ar":"\u0647\u0630\u0647 \u0627\u0644\u0635\u0641\u062d\u0629 \u063a\u064a\u0631 \u0645\u062a\u0627\u062d\u0629 \u0641\u064a \u0627\u0644\u0639\u0631\u0628\u064a\u0629.","ca":"Aquesta p\u00e0gina no est\u00e0 disponible en catal\u00e0.","is":"\u00deessi s\u00ed\u00f0a er ekki tilt\u00e6k \u00ed \u00edslenska.","he":"This page is not available in \u05e2\u05d1\u05e8\u05d9\u05ea.","kl":"This page is not available in kalaallisut.","ja":"\u3053\u306e\u30da\u30fc\u30b8\u306f\u65e5\u672c\u8a9e\u3067\u306f\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u305b\u3093\u3002","lb":"D\u00ebs S\u00e4it ass net op L\u00ebtzebuergesch zoug\u00e4nglech.","nb":"Denne siden er ikke tilgjengelig p\u00e5 norsk.","ru":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439 \u043e\u0442\u0441\u0443\u0442\u0441\u0442\u0432\u0443\u0435\u0442 \u0434\u043b\u044f \u043f\u0435\u0440\u0435\u0432\u043e\u0434\u0430 \u044d\u0442\u043e\u0439 \u0441\u0442\u0440\u0430\u043d\u0438\u0446\u044b","sw":"This page is not available in Kiswahili.","tr":"Bu sayfa t\u00fcrk\u00e7e dilinde mevcut de\u011fildir.","uk":"y\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430 \u0432\u0456\u0434\u0441\u0443\u0442\u043d\u044f \u0434\u043b\u044f \u043f\u0435\u0440\u0435\u043a\u043b\u0430\u0434\u0443 \u0446\u0456\u0454\u0457 \u0441\u0442\u043e\u0440\u0456\u043d\u043a\u0438.","zh-hans":"\u672c\u9875\u9762\u5e76\u65e0\u4e2d\u6587\u7248\u672c\u3002"},"translation_message":{"bg":"\u0412\u0435\u0440\u0441\u0438\u044f \u043d\u0430 \u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438 \u0435\u0437\u0438\u043a \u0435 \u043d\u0430\u043b\u0438\u0447\u043d\u0430 \u0447\u0440\u0435\u0437 eTranslation, \u0443\u0441\u043b\u0443\u0433\u0430\u0442\u0430 \u0437\u0430 \u043c\u0430\u0448\u0438\u043d\u0435\u043d \u043f\u0440\u0435\u0432\u043e\u0434 \u043d\u0430 \u0415\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u043a\u0430\u0442\u0430 \u043a\u043e\u043c\u0438\u0441\u0438\u044f.","es":"El espa\u00f1ol est\u00e1 disponible mediante eTranslation, el servicio de traducci\u00f3n autom\u00e1tica de la Comisi\u00f3n Europea.","cs":"\u010cesk\u00fd p\u0159eklad textu je k dispozici prost\u0159ednictv\u00edm eTranslation, slu\u017eby strojov\u00e9ho p\u0159ekladu Evropsk\u00e9 komise.","da":"En overs\u00e6ttelse til dansk f\u00e5r du via eTranslation, som er Europa-Kommissionens maskinovers\u00e6ttelsestjeneste.","de":"Deutsch ist \u00fcber eTranslation verf\u00fcgbar, den maschinellen \u00dcbersetzungsdienst der Europ\u00e4ischen Kommission.","et":"Eesti keel on Euroopa Komisjoni masint\u00f5lketeenuses eTranslation k\u00e4ttesaadav.","el":"\u0397 \u03ad\u03ba\u03b4\u03bf\u03c3\u03b7 \u03c3\u03c4\u03b1 \u03b5\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac \u03b5\u03af\u03bd\u03b1\u03b9 \u03b4\u03b9\u03b1\u03b8\u03ad\u03c3\u03b9\u03bc\u03b7 \u03bc\u03ad\u03c3\u03c9 \u03c4\u03b7\u03c2 \u03c5\u03c0\u03b7\u03c1\u03b5\u03c3\u03af\u03b1\u03c2 eTranslation, \u03c4\u03b7\u03c2 \u03c5\u03c0\u03b7\u03c1\u03b5\u03c3\u03af\u03b1\u03c2 \u03b1\u03c5\u03c4\u03cc\u03bc\u03b1\u03c4\u03b7\u03c2 \u03bc\u03b5\u03c4\u03ac\u03c6\u03c1\u03b1\u03c3\u03b7\u03c2 \u03c4\u03b7\u03c2 \u0395\u03c5\u03c1\u03c9\u03c0\u03b1\u03ca\u03ba\u03ae\u03c2 \u0395\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2.","en":"English is available via eTranslation, the European Commission\u0027s machine translation service.","fr":"Le fran\u00e7ais est disponible par eTranslation, le service de traduction automatique de la Commission europ\u00e9enne.","ga":"T\u00e1 an Ghaeilge ar f\u00e1il tr\u00ed eTranslation, seirbh\u00eds meais\u00ednaistri\u00fach\u00e1in an Choimisi\u00fain Eorpaigh.","hr":"Tekst na hrvatskom dostupan je samo kao strojni prijevod koji je generirala usluga eTranslation Europske komisije.","it":"L\u0027italiano \u00e8 disponibile in versione tradotta automaticamente dal servizio eTranslation della Commissione europea.","lv":"Tulkojums latvie\u0161u valod\u0101 ir pieejams, izmantojot Eiropas Komisijas ma\u0161\u012bntulko\u0161anas pakalpojumu \u201ceTranslation\u201d.","lt":"Vertim\u0105 \u012f lietuvi\u0173 kalb\u0105 galima sugeneruoti Europos Komisijos ma\u0161ininio vertimo priemone \u201eeTranslation\u201c.","hu":"Ez a tartalom el\u00e9rhet\u0151 magyar nyelven az eTranslation, az Eur\u00f3pai Bizotts\u00e1g ford\u00edt\u00f3programja \u00e1ltal biztos\u00edtott g\u00e9pi ford\u00edt\u00e1s form\u00e1j\u00e1ban.","mt":"Il-Malti hu disponibbli permezz tal-eTranslation, is-servizz tat-traduzzjoni awtomatika tal-Kummissjoni Ewropea.","nl":"Nederlands is beschikbaar via eTranslation, de machinevertaaldienst van de Europese Commissie.","pl":"T\u0142umaczenie na j\u0119zyk polski zostanie wygenerowane przy pomocy serwisu t\u0142umaczenia maszynowego Komisji Europejskiej eTranslation.","pt-pt":"Vers\u00e3o em portugu\u00eas dispon\u00edvel atrav\u00e9s do servi\u00e7o eTranslation, o servi\u00e7o de tradu\u00e7\u00e3o autom\u00e1tica da Comiss\u00e3o Europeia.","ro":"Versiunea \u00een limba rom\u00e2n\u0103 este disponibil\u0103 prin intermediul eTranslation, serviciul de traducere automat\u0103 al Comisiei Europene.","sk":"Preklad do sloven\u010diny je dostupn\u00fd cez eTranslation, slu\u017ebu strojov\u00e9ho prekladu Eur\u00f3pskej komisie.","sl":"Slovenski prevod je na voljo prek eTranslation, strojnega prevajalnika Evropske komisije.","fi":"Euroopan komission eTranslation-palvelusta voi tilata suomenkielisen konek\u00e4\u00e4nn\u00f6ksen.","sv":"Svenska kan f\u00e5s via eTranslation, EU-kommissionens maskin\u00f6vers\u00e4ttningsverktyg.","ar":"@\u0627\u0644\u0644\u063a\u0629 \u0645\u062a\u0627\u062d\u0629 \u0645\u0646 \u062e\u0644\u0627\u0644 eTranslation\u060c \u062e\u062f\u0645\u0629 \u0627\u0644\u062a\u0631\u062c\u0645\u0629 \u0627\u0644\u0622\u0644\u064a\u0629 \u0645\u0646 \u0627\u0644\u0645\u0641\u0648\u0636\u064a\u0629 \u0627\u0644\u0623\u0648\u0631\u0648\u0628\u064a\u0629.","ca":"catal\u00e0 est\u00e0 disponible a trav\u00e9s d\u2019eTranslation, el servei de traducci\u00f3 autom\u00e0tica de la Comissi\u00f3 Europea.","is":"\u00edslenska er f\u00e1anlegt \u00ed gegnum eTranslation, v\u00e9l\u00fe\u00fd\u00f0ingar\u00fej\u00f3nustu framkv\u00e6mdastj\u00f3rnar Evr\u00f3pusambandsins.","he":"\u05e2\u05d1\u05e8\u05d9\u05ea is available via eTranslation, the European Commission\u0027s machine translation service.","kl":"kalaallisut is available via eTranslation, the European Commission\u0027s machine translation service.","ja":"\u65e5\u672c\u8a9e\u306f\u6b27\u5dde\u59d4\u54e1\u4f1a\u306e\u6a5f\u68b0\u7ffb\u8a33\u30b5\u30fc\u30d3\u30b9\u3067\u3042\u308beTranslation\u3092\u901a\u3058\u3066\u5229\u7528\u3067\u304d\u307e\u3059\u3002","lb":"L\u00ebtzebuergesch ass zoug\u00e4nglech via eTranslation, den automateschen Iwwersetzungsd\u00e9ngscht vun der Europ\u00e4escher Kommissioun.","nb":"norsk er tilgjengelig via eTranslation, EU-kommisjonens tjeneste for maskinoversettelse.","ru":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439 \u0434\u043e\u0441\u0442\u0443\u043f\u0435\u043d \u0432 eTranslation, \u0441\u043b\u0443\u0436\u0431\u0435 \u043c\u0430\u0448\u0438\u043d\u043d\u043e\u0433\u043e \u043f\u0435\u0440\u0435\u0432\u043e\u0434\u0430 \u0415\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u043a\u043e\u0439 \u043a\u043e\u043c\u0438\u0441\u0441\u0438\u0438.","sw":"Kiswahili is available via eTranslation, the European Commission\u0027s machine translation service.","tr":"t\u00fcrk\u00e7e, Avrupa Komisyonu\u0027nun makine terc\u00fcmesi hizmeti olan eTranslation \u00fczerinde mevcuttur.","uk":"y\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430 \u0456\u0441\u043d\u0443\u0454 \u0432 eTranslation, \u0441\u043b\u0443\u0436\u0431\u0456 \u043c\u0430\u0448\u0438\u043d\u043d\u043e\u0433\u043e \u043f\u0435\u0440\u0435\u043a\u043b\u0430\u0434\u0443 \u0404\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u043e\u0457 \u043a\u043e\u043c\u0456\u0441\u0456\u0457.","zh-hans":"\u53ef\u901a\u8fc7\u6b27\u76df\u59d4\u5458\u4f1a\u7684\u673a\u5668\u7ffb\u8bd1\u670d\u52a1eTranslation\u83b7\u5f97\u4e2d\u6587\u7248\u672c\u3002"},"translate_link":{"bg":"\u041f\u0440\u0435\u0432\u043e\u0434 \u043d\u0430 \u0431\u044a\u043b\u0433\u0430\u0440\u0441\u043a\u0438","es":"Traducir al espa\u00f1ol","cs":"P\u0159elo\u017eit do \u010de\u0161tiny","da":"Overs\u00e6t til dansk","de":"Ins Deutsche \u00fcbersetzen","et":"T\u00f5lgi eesti keelde","el":"\u039c\u03b5\u03c4\u03ac\u03c6\u03c1\u03b1\u03c3\u03b7 \u03c3\u03c4\u03b1 \u03b5\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ac","en":"Translate to English","fr":"Traduire en fran\u00e7ais","ga":"Aistrigh go Gaeilge","hr":"Prevedi na hrvatski","it":"Tradurre in italiano","lv":"P\u0101rtulkot latvie\u0161u valod\u0101","lt":"I\u0161versti \u012f lietuvi\u0173 kalb\u0105","hu":"Ford\u00edt\u00e1s magyarra","mt":"Ittradu\u010bi g\u0127all-Malti","nl":"Vertalen in het Nederlands","pl":"Przet\u0142umacz na j\u0119zyk polski","pt-pt":"Traduzir para portugu\u00eas","ro":"Traducere \u00een limba rom\u00e2n\u0103","sk":"Prelo\u017ei\u0165 do sloven\u010diny","sl":"Prevedi v sloven\u0161\u010dino","fi":"K\u00e4\u00e4nn\u00e4 suomeksi","sv":"\u00d6vers\u00e4tt till svenska","ar":"\u062a\u0631\u062c\u0645 \u0625\u0644\u0649 \u0627\u0644\u0639\u0631\u0628\u064a\u0629.","ca":"Tradueix-la a catal\u00e0","is":"\u00de\u00fd\u00f0a \u00e1 \u00edslenska","he":"Translate to \u05e2\u05d1\u05e8\u05d9\u05ea","kl":"Translate to kalaallisut","ja":"\u65e5\u672c\u8a9e\u306b\u7ffb\u8a33","lb":"Op L\u00ebtzebuergesch iwwersetzen.","nb":"Oversett til norsk","ru":"\u041f\u0435\u0440\u0435\u0432\u0435\u0441\u0442\u0438 \u043d\u0430 \u0440\u0443\u0441\u0441\u043a\u0438\u0439","sw":"Translate to Kiswahili","tr":"t\u00fcrk\u00e7e diline terc\u00fcme et","uk":"\u041f\u0435\u0440\u0435\u043a\u043b\u0430\u0441\u0442\u0438 \u043d\u0430 y\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430.","zh-hans":"\u7ffb\u8bd1\u4e3a\u4e2d\u6587"},"disclaimer_link":{"bg":"\u0412\u0430\u0436\u043d\u0430 \u0438\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0438\u044f \u043e\u0442\u043d\u043e\u0441\u043d\u043e \u043c\u0430\u0448\u0438\u043d\u043d\u0438\u044f \u043f\u0440\u0435\u0432\u043e\u0434","es":"Informaci\u00f3n importante sobre la traducci\u00f3n autom\u00e1tica","cs":"D\u016fle\u017eit\u00e9 informace o strojov\u00e9m p\u0159ekladu","da":"Vigtig information om maskinovers\u00e6ttelser","de":"Das sollten Sie \u00fcber maschinelle \u00dcbersetzung wissen","et":"Oluline teave masint\u00f5lke kohta","el":"\u03a3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b1\u03c5\u03c4\u03cc\u03bc\u03b1\u03c4\u03b7 \u03bc\u03b5\u03c4\u03ac\u03c6\u03c1\u03b1\u03c3\u03b7","en":"Important information about machine translation","fr":"Informations importantes concernant la traduction automatique","ga":"Eolas t\u00e1bhachtach faoin meais\u00ednaistri\u00fach\u00e1n","hr":"Va\u017ene informacije o strojnom prevo\u0111enju","it":"Informazioni importante sulla traduzione automatica","lv":"Svar\u012bga inform\u0101cija par ma\u0161\u012bntulko\u0161anu","lt":"Svarbi informacija apie ma\u0161inin\u012f vertim\u0105","hu":"Fontos tudnival\u00f3k a g\u00e9pi ford\u00edt\u00e1sr\u00f3l","mt":"Informazzjoni importanti dwar it-traduzzjoni awtomatika","nl":"Belangrijke informatie over machinevertaling","pl":"Wa\u017cne informacje o t\u0142umaczeniu maszynowym","pt-pt":"Informa\u00e7\u00f5es importantes sobre a tradu\u00e7\u00e3o autom\u00e1tica","ro":"Informa\u021bii importante despre traducerea automat\u0103","sk":"D\u00f4le\u017eit\u00e9 inform\u00e1cie o strojovom preklade","sl":"Pomembne informacije o strojnem prevodu","fi":"T\u00e4rke\u00e4\u00e4 tietoa konek\u00e4\u00e4nn\u00f6ksist\u00e4","sv":"Viktigt om maskin\u00f6vers\u00e4ttning","ar":"\u0645\u0639\u0644\u0648\u0645\u0627\u062a \u0647\u0627\u0645\u0629 \u062d\u0648\u0644 \u0627\u0644\u062a\u0631\u062c\u0645\u0629 \u0627\u0644\u0622\u0644\u064a\u0629","ca":"Informaci\u00f3 important sobre la traducci\u00f3 autom\u00e0tica","is":"Mikilv\u00e6gar uppl\u00fdsingar um v\u00e9lr\u00e6na \u00fe\u00fd\u00f0ingu","he":"Important information about machine translation","kl":"Important information about machine translation","ja":"\u6a5f\u68b0\u7ffb\u8a33\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u60c5\u5831","lb":"Wichteg Informatiounen fir d\u0027automatesch Iwwersetzung","nb":"Viktig informasjon om maskinoversettelse","ru":"\u0412\u0430\u0436\u043d\u0430\u044f \u0438\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0438\u044f \u043e \u043c\u0430\u0448\u0438\u043d\u043d\u043e\u043c \u043f\u0435\u0440\u0435\u0432\u043e\u0434\u0435","sw":"Important information about machine translation","tr":"Makine terc\u00fcmesi hakk\u0131nda \u00f6nemli bilgiler","uk":"\u0412\u0430\u0436\u043b\u0438\u0432\u0430 \u0456\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0456\u044f \u043f\u0440\u043e \u043c\u0430\u0448\u0438\u043d\u043d\u0438\u0439 \u043f\u0435\u0440\u0435\u043a\u043b\u0430\u0434","zh-hans":"\u5173\u4e8e\u673a\u5668\u7ffb\u8bd1\u7684\u91cd\u8981\u4fe1\u606f"},"close_message":{"bg":"\u0417\u0430\u0442\u0432\u0430\u0440\u044f\u043d\u0435 \u043d\u0430 \u0441\u044a\u043e\u0431\u0449\u0435\u043d\u0438\u0435\u0442\u043e","es":"Cerrar este mensaje","cs":"Zav\u0159\u00edt tuto zpr\u00e1vu","da":"Luk denne meddelelse","de":"Diese Nachricht schlie\u00dfen","et":"Sulge teade","el":"\u039a\u03bb\u03b5\u03af\u03c3\u03b9\u03bc\u03bf \u03b1\u03c5\u03c4\u03bf\u03cd \u03c4\u03bf\u03c5 \u03bc\u03b7\u03bd\u03cd\u03bc\u03b1\u03c4\u03bf\u03c2","en":"Close this message","fr":"Fermer ce message","ga":"D\u00fan an teachtaireacht seo","hr":"Zatvori ovu poruku","it":"Chiudi il messaggio","lv":"Aizv\u0113rt \u0161o zi\u0146ojumu","lt":"U\u017edaryti \u0161i\u0105 \u017einut\u0119","hu":"\u00dczenet bez\u00e1r\u00e1sa","mt":"Ag\u0127laq dan il-messa\u0121\u0121","nl":"Bericht sluiten","pl":"Zamknij t\u0119 wiadomo\u015b\u0107","pt-pt":"Fechar esta mensagem","ro":"\u00cenchide\u021bi acest mesaj","sk":"Zatvori\u0165 t\u00fato spr\u00e1vu","sl":"Zapri to sporo\u010dilo","fi":"Sulje t\u00e4m\u00e4 viesti","sv":"St\u00e4ng meddelandet","ar":"\u0627\u0642\u0641\u0644 \u0647\u0630\u0647 \u0627\u0644\u0631\u0633\u0627\u0644\u0629","ca":"Tanca aquest missatge","is":"Loka skilabo\u00f0unum","he":"Close this message","kl":"Close this message","ja":"\u3053\u306e\u30e1\u30c3\u30bb\u30fc\u30b8\u3092\u9589\u3058\u308b","lb":"D\u00ebs Noriicht zoumaachen","nb":"Lukk meldingen","ru":"\u0417\u0430\u043a\u0440\u044b\u0442\u044c \u044d\u0442\u043e \u0441\u043e\u043e\u0431\u0449\u0435\u043d\u0438\u0435","sw":"Close this message","tr":"Bu mesaj\u0131 kapat","uk":"\u0417\u0430\u043a\u0440\u0438\u0442\u0438 \u0446\u0435 \u043f\u043e\u0432\u0456\u0434\u043e\u043c\u043b\u0435\u043d\u043d\u044f","zh-hans":"\u5173\u95ed\u6b64\u4fe1\u606f"}}}},"ewcms_theme":{"defaultLanguagePageTitle":"Guidance - MDCG endorsed documents and other guidance"},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true},"user":{"uid":0,"permissionsHash":"cdfe7db39567fcb6086f554ab05da9eb902eec692d88418234da17f8644f58f8"}}





